Cargando…
Loss and Gain of Tolerance to Pancreatic Glycoprotein 2 in Celiac Disease
BACKGROUND: Autoantibodies against pancreatic secretory-granule membrane glycoprotein 2 (GP2) have been demonstrated in patients with Crohn’s disease but recently also with celiac disease (CD). Both entities are characterized by intestinal barrier impairment with increased gut permeability. Pathophy...
Autores principales: | Laass, Martin W., Röber, Nadja, Range, Ursula, Noß, Lydia, Roggenbuck, Dirk, Conrad, Karsten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4457647/ https://www.ncbi.nlm.nih.gov/pubmed/26047356 http://dx.doi.org/10.1371/journal.pone.0128104 |
Ejemplares similares
-
Simultaneous detection of celiac disease-specific IgA antibodies and total IgA
por: Grossmann, Kai, et al.
Publicado: (2016) -
Pancreatic-specific autoantibodies to glycoprotein 2 mirror disease location and behaviour in younger patients with Crohn’s disease
por: Bogdanos, Dimitrios P, et al.
Publicado: (2012) -
PR3-ANCAs Detected by Third-Generation ELISA Predicts Severe Disease and Poor Survival in Primary Sclerosing Cholangitis
por: Lopens, Steffi, et al.
Publicado: (2022) -
Identification of Chitinase-3-Like Protein 1 as a Novel Neutrophil Antigenic Target in Crohn’s Disease
por: Deutschmann, Claudia, et al.
Publicado: (2019) -
Stable Expression of Human Muscle-Specific Kinase in HEp-2 M4 Cells for Automatic Immunofluorescence Diagnostics of Myasthenia Gravis
por: George, Sandra, et al.
Publicado: (2014)